{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:22:00Z","timestamp":1789050120057,"version":"build-2803163510"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>It\u2019s been widely reported that the new coronavirus has adverse effects on the musculoskeletal system. The primary goal of this study is to establish the frequency of musculoskeletal complaintswith extended COVID syndrome. This retrospective cohort research examined the occurrence of musculoskeletal problems in patients with chronic COVID-19 syndrome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and Methods:<\/jats:title>\n                    <jats:p>About 100 COVID-19patients tested positive, of which 27 (27.0%) had a minimum of one orthopedic impairment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Patients with orthopedic conditions were significantly younger than those without (53.7 years vs. 58.1 years, p = 0.003), and their incidence was significantly higher in obese than non-obese patients (p = 0.022).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Furthermore, patients with diabetes had significantly more orthopedic symptoms than those with cardiac or pulmonary complications. According to our research, patients who are obese or diabetic have a higher probability of experiencing musculoskeletal symptoms when infected with COVID-19. Additionally, analysis is needed to determine whether these orthopedic conditions persist during active disease and post-infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jpbs.jpbs_88_23","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T02:07:24Z","timestamp":1689127644000},"page":"S665-S668","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Orthopedic Manifestations and Post-COVID-19 Infection"],"prefix":"10.4103","volume":"15","author":[{"given":"Priti R.","family":"Sinha","sequence":"first","affiliation":[{"name":"Department of Orthopaedics, GS Medical College and Hospital, Pilkhuwa, Hapur, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Mallick","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Santosh Medical College, Ghaziabad, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramjee L.","family":"Sahu","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Saraswati Institute of Medical Sciences, Pilkhuwa, Hapur, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,7,5]]},"reference":[{"key":"R1-20240829","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00508-020-01760-4","article-title":"Clinical manifestations of COVID-19 in the general population:Systematic review","volume":"133","author":"da Rosa Mesquita","year":"2021","journal-title":"Wien Klin Wochenschr"},{"key":"R2-20240829","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/cei.12445","article-title":"Cytokines in immune-mediated inflammatory myopathies:Cellular sources, multiple actions and therapeutic implications","volume":"178","author":"Moran","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"R3-20240829","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13018-020-01702-w","article-title":"Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients","volume":"15","author":"Cipollaro","year":"2020","journal-title":"J Orthop Surg Res"},{"key":"R4-20240829","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/00325481.2020.1786964","article-title":"COVID-19 and comorbidities:A systematic review and meta-analysis","volume":"132","author":"Gold","year":"2020","journal-title":"Postgrad Med"},{"key":"R5-20240829","doi-asserted-by":"crossref","first-page":"653","DOI":"10.23736\/S1973-9087.20.06563-6","article-title":"Assessment of musculoskeletal pain, fatigue and grip strength in hospitalized patients with COVID-19","volume":"57","author":"Tuzun","year":"2021","journal-title":"Eur J Phys Rehabil Med"},{"key":"R6-20240829","first-page":"151","article-title":"COVID-19 and diabetes:A bidirectional relationship","volume":"33","author":"Lima-Mart\u00ednez","year":"2021","journal-title":"Clin Investig Arterioscler"},{"key":"R7-20240829","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2147\/COPD.S49621","article-title":"Epidemiology and clinical impact of major comorbidities in patients with COPD","volume":"9","author":"Smith","year":"2014","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"R8-20240829","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1111\/all.14309","article-title":"COVID-19 in a designated infectious diseases hospital outside Hubei Province, China","volume":"75","author":"Cai","year":"2020","journal-title":"Allergy"},{"key":"R9-20240829","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/cid\/ciaa243","article-title":"Clinical features and short-term outcomes of 102 patients with coronavirus disease 2019 in Wuhan, China","volume":"71","author":"Cao","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R10-20240829","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ijid.2020.04.041","article-title":"Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019","volume":"95","author":"Zhu","year":"2020","journal-title":"Int J Infect Dis"},{"key":"R11-20240829","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.3389\/fimmu.2019.01071","article-title":"Impact of obesity on influenza A virus pathogenesis, immune response, and evolution","volume":"10","author":"Honce","year":"2019","journal-title":"Front Immunol"},{"key":"R12-20240829","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/infdis\/jir729","article-title":"Impaired wound healing predisposes obese mice to severe influenza virus infection","volume":"205","author":"O'Brien","year":"2012","journal-title":"J Infect Dis"},{"key":"R13-20240829","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nm0995-953","article-title":"Increased obese mRNA expression in omental fat cells from massively obese humans","volume":"1","author":"Hamilton","year":"1995","journal-title":"Nat Med"},{"key":"R14-20240829","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1750-2659.2011.00254.x","article-title":"Obese mice have increased morbidity and mortality compared to non-obese mice during infection with the 2009 pandemic H1N1 influenza virus","volume":"5","author":"Easterbrook","year":"2011","journal-title":"Influenza Other Respir Viruses"},{"key":"R15-20240829","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.7861\/clinmed.2020-0239","article-title":"The potential impacts of obesity on COVID-19","volume":"20","author":"Albashir","year":"2020","journal-title":"Clin Med (Lond)"},{"key":"R16-20240829","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1001\/jama.289.21.JOC30885","article-title":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area","volume":"289","author":"Booth","year":"2003","journal-title":"JAMA"},{"key":"R17-20240829","doi-asserted-by":"crossref","first-page":"e3377","DOI":"10.1002\/dmrr.3377","article-title":"Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19)","volume":"37","author":"Zhou","year":"2021","journal-title":"Diabetes Metab Res Rev"},{"key":"R18-20240829","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(20)30627-9","article-title":"COVID-19 and Italy:What next?","volume":"395","author":"Remuzzi","year":"2020","journal-title":"Lancet"},{"key":"R19-20240829","doi-asserted-by":"crossref","first-page":"e3319","DOI":"10.1002\/dmrr.3319","article-title":"Diabetes is a risk factor for the progression and prognosis of COVID-19","volume":"36","author":"Guo","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"R20-20240829","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1136\/heartjnl-2020-316909","article-title":"Do underlying cardiovascular diseases have any impact on hospitalised patients with COVID-19?","volume":"106","author":"Zhang","year":"2020","journal-title":"Heart"},{"key":"R21-20240829","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"R22-20240829","doi-asserted-by":"crossref","first-page":"2002108","DOI":"10.1183\/13993003.02108-2020","article-title":"COVID-19 and COPD","volume":"56","author":"Leung","year":"2020","journal-title":"Eur Respir J"},{"key":"R23-20240829","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.accpm.2020.04.001","article-title":"SARS-CoV-2 in Spanish intensive care units:Early experience with 15-day survival in Vitoria","volume":"39","author":"Barrasa","year":"2020","journal-title":"Anaesth Crit Care Pain Med"},{"key":"R24-20240829","doi-asserted-by":"crossref","first-page":"154262","DOI":"10.1016\/j.metabol.2020.154262","article-title":"Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York","volume":"108","author":"Palaiodimos","year":"2020","journal-title":"Metabolism"},{"key":"R25-20240829","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1056\/NEJMoa2004500","article-title":"Covid-19 in critically ill patients in the seattle region-case series","volume":"382","author":"Bhatraju","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Journal of Pharmacy and Bioallied Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jpbs.jpbs_88_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:13:26Z","timestamp":1787760806000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jpbs.jpbs_88_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":25,"journal-issue":{"issue":"Suppl 1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jpbs.jpbs_88_23","relation":{},"ISSN":["0976-4879","0975-7406"],"issn-type":[{"value":"0976-4879","type":"print"},{"value":"0975-7406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"2023-01-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}